Terms of Reference (ToR) for ConsultationDemand Creation for New Generation ARVs – Acceptance Study Among PLWHIV 1. Context and Justification The Middle East and North Africa (MENA) region faces a growing HIV epidemic,Read More
Since the beginning of the HIV epidemic, Community Advisory Boards (CABs) constituted an effective tool to link communities as real partners with researchers and drug manufacturers; educate people living with HIV and theirRead More
ITPC-MENA is pleased to inform you that Mr. Othmane MARRAKCHI has recently joined ITPC-MENA as Advocacy Officer for Access to Medicines. In this position, Mr. Othmane MARRAKCHI will manage the development and implementationRead More
Information on the APPLICATION PROCESS to be a member of the Middle East and North Africa Community Advisory Board (MENACAB) steering committee — KEY DATES: Application submission opening: 25th September 2021 Application submissionRead More
The International Treatment Preparedness Coalition (ITPC) conducted its first Global HIV Treatment Access Survey in 2018 to assess the current state of HIV/AIDS care and treatment services in 14 countries and to documentRead More
ALCS – AMDH – ITPC-MENA Joint Press Release Casablanca May 13, 2020 Moroccan civil society calls for government use licenses as national generics manufactures are banned from producing anti-COVID19 drugs by GILEAD OnRead More
Marrakech, 13 December 2018 The Global Fund Civil Society Platform for Middle East and North Africa (MENA) held The “Regional Leaning and Sharing Forum” in Marrakech on 11 – 12 December 2018. TheRead More
Marrakech, 13 December 2018 The Global Fund Civil Society Platform for Middle East and North Africa (MENA) held The “Regional Leaning and Sharing Forum” in Marrakech on 11 – 12 December 2018. TheRead More
The Community Advisory Board (CAB) constitutes a space of exchange between advocates from the MENA region, researchers and drug manufacturers, with the aim to educate people living with HIV and their advocates onRead More
Are you advocates of the right to health and access to treatment? or activist living with HIV, hepatitis C, hepatitis B or tuberculosis in the North Africa and Middle East (MENA) region? WouldRead More
